Anderson Thomas has filed 5 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 30000 shares of ZEVRA THERAPEUTICS, INC. ($ZVRA) on May 29, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Anderson Thomas | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| July 16, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Anderson Thomas | Director | P | Common Stock | 10000 | $6.81 | 20,000.0000 | 0 | 100.00% | 0.00% |
| May 13, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Anderson Thomas | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Anderson Thomas | Director | P | Common Stock | 10000 | $4.88 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 7, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Anderson Thomas | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |